Boston ScientificvsMerck & Company

BSX and MRK stock compared: price, dividend, valuation and results, from SEC filings.

BSX

Boston Scientific Corporation

$43.33

Value $64.3B

-0.84%
BSX's page

MRK

Merck & Company, Inc.

$143.34

Value $354B

-0.75%
MRK's page

Boston Scientific (BSX) has a market value of $64.3B and Merck & Company (MRK) $354B. Over the last year, with dividends, BSX moved -57.8% and MRK +58.8%. The P/E is 18.4 for BSX and 144.5 for MRK. Dividend yield: BSX none, MRK 2.37%.

At a glance

The main figures of both. A bar only shows which number is larger, not which is better.

  • Market value

    BSX$64.3B

    MRK$354B

    MRK is 5.5 times BSX

  • Revenue, 12 months

    BSX$21.1B

    MRK$67.4B

    MRK is 3.2 times BSX

  • Net income, 12 months

    BSX$3.5B

    MRK$2.5B

    BSX is 1.4 times MRK

  • Operating margin

    BSX18.7%

    MRK–

  • ROIC

    BSX8.5%

    MRK3.9%

    4.6 points apart

  • P/E

    BSX18.4

    MRK144.5

    MRK is 7.9 times BSX

  • Dividend yield

    BSX0.0%

    MRK2.4%

    2.4 points apart

  • 5-year return

    BSX+4.6%

    MRK+98.5%

    93.9 points apart

A fainter bar means a negative number. The 5-year return includes dividends.

The price over time

Both start at 100 at the beginning of the period, so the lines show how much each changed. With dividends means each dividend buys more shares.

BSX+4.6%

MRK+98.5%

10015020025020222023202420252026
Returns by period
PeriodBSXWith dividendsMRKWith dividends
1 year since November 14, 2025-57.8%Price -57.8%+58.8%Price +54.3%
3 years since November 17, 2023-20.3%-7.3% a yearPrice -20.3%+54.4%+15.6% a yearPrice +40.9%
5 years since November 16, 2021+4.6%+0.9% a yearPrice +4.6%+98.5%+14.7% a yearPrice +70.4%
10 years since November 17, 2016+100.5%+7.2% a yearPrice +100.5%+225.1%+12.5% a yearPrice +139.6%

Each cell: the total return with dividends, its yearly rate, and the price change alone. Before taxes and costs. Past returns do not predict future ones.

Every figure

As on each company's page. A description, not a recommendation: no one figure says which is better.

BSXBoston ScientificMRKMerck & Company

Valuation

BSXMRK
Valuation
Price$43.33$143.34
Market value$64.3B$354B
Enterprise value (EV)$75.6B$399B
P/E18.4144.5
P/E, 5-year median57.814.8
P/B2.57.9
EV/EBIT19.283.7
Free cash flow yield5.2%4.2%

Results and growth

BSXMRK
Results and growth
Revenue, 12 months$21.1B$67.4B
Net income, 12 months$3.5B$2.5B
Free cash flow, 12 months$3.3B$14.7B
Earnings per share, 12 months$2.36$0.98
Revenue growth, year on year19.9%1.3%
Revenue growth a year, past+15.2%over 5 years+9.4%over 5 years
EPS growth a year, past–+21.2%over 5 years

Margins and returns on capital

BSXMRK
Margins and returns on capital
Gross margin69.2%71.8%
Operating margin18.7%–
Net margin16.6%3.6%
ROIC8.5%3.9%
ROE14.1%5.2%

Balance sheet

BSXMRK
Balance sheet
Cash$609M$9.7B
Total debt$12.0B$53.8B
Net debt / EBITDA2.15.7
Interest cover10.5×2.4×

Dividends and buybacks

BSXMRK
Dividends and buybacks
Dividend yield–2.4%
Dividend per share, 12 months–$3.40
Dividend growth a year, past–+5.8%over 5 years
Buyback yield–1.4%
Shareholder yield–3.8%

Last 12 months from the latest 10-Q and 10-K. Value, P/E and yields at today's price. A dash means the figure does not exist or did not pass our checks.

Questions: BSX or MRK

Didn't find what you were looking for?

Ask us
Which is bigger, Boston Scientific or Merck & Company?

By market value, Merck & Company ($354B) is about 5.5 times Boston Scientific ($64.3B), at today's prices.

How did BSX and MRK stock do over the last 10 years?

Since November 17, 2016, BSX's price moved +100.5% and MRK's +139.6%. With dividends: BSX +100.5% (+7.2% a year), MRK +225.1% (+12.5% a year). Past returns do not predict future ones.

Which pays the higher dividend, BSX or MRK?

The dividend yield at today's price is none for Boston Scientific and 2.37% for Merck & Company. Over the last twelve months they paid – and $3.40 per share.

What is the P/E of BSX and MRK?

At today's price, the P/E is 18.4 for BSX and 144.5 for MRK. The median of the last five years was 57.8 and 14.8, which shows where each stands against its own past.

Which has the higher profit margins, Boston Scientific or Merck & Company?

Over the last twelve months, the net margin was 16.6% for Boston Scientific and 3.6% for Merck & Company, and the operating margin 18.7% and –. Revenue was $21.1B and $67.4B.

Which is the better investment, Boston Scientific or Merck & Company?

The page does not answer that and does not suggest buying or selling. It puts the two companies' numbers side by side, from their SEC filings, for you to read and form your own view. The decision depends on your goals and situation.

Other comparisons

With each of the two, and with the largest in its sector.

Related pages

The other pages on US stocks, free to read. On the company pages, the last three fiscal years are open to everyone, five with a free account, and every year with Ploutos Investor.

Descriptive data from SEC filings and market prices.